Phase II trials in the EORTC
- 作者The protocol review committee the data center; the research; treatment division; and the new drug development office
- 卷第33卷
- 期第9期
- 印刷ISSN0959-8049
- 文件大小299.67KB
- 发表时间1997
- DOI10.1016/s0959-8049(97)90049-6
Value of infliximab (Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia GroupBaron, F.; Suciu, S.; Amadori, S.; Muus, P.; Zwierzina, H.; Denzlinger, C.; Delforge, M.; Thyss, A.; Selleslag, D.; Indrak, K.; Ossenkoppele, G.; de Witte, T. · Haematologica · 2012
Single agent activity of rhizoxin in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials groupLung Cancer · 1996
Docetaxel (TaxotereR) is active in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group (ECTG)Lung Cancer · 1995
Taxotere is active in small cell lung cancer (SCLC) a phase II trial of the eortc early clinical trials group (ECTG)Smyth, JF; Bowman, A; Smith, I; Sessa, C; Kaye, S · European Journal of Cancer · 1993
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening GroupV. Urosevic; Ph. Chollet; A. Adenis; J. Chauvergne; P. Fargeot; H. Roche; P. Kerbrat; M.A. Lentz; P. Fumoleau; B. Chevallier · 1996
Radiochemotherapy in locally advanced anal carcinoma (LAAC). Results of the 22953 EORTC phase II trialJ.F. Bosset; F. Roelofsen; D. Morgan; V. Budach; R.O. Mirimanoff; J.J. Jager; E. Van der Steen-Banasik; H. Heidersdorf; M. Puyraveau; M. Mercier · 2001
Topotecan in colorectal cancer: A phase II study of the EORTC early clinical trials groupCreemers, G. J.; Wanders, J.; Gamucci,, T.; Vallentin, S.; Dirix, L. Y.; Schöffski, P.; Hudson, I.; Verweij, J. · Annals of Oncology · 1995